← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleShenzhen Geno-Immune Medical In…Phase 2

Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20 (Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20)

CD19 Negative B-cell Malignancies · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleDonghua ZhangPreclinical

Infusion of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies (Infusion of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies)

Relapsed/Refractory B-cell Malignancies · FRα

#FR#CGT#Preclinical#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleMemorial Sloan Kettering Cancer…Phase 1

Infusion of MCARH109 T cells (Infusion of MCARH109 T cells)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShenzhen Geno-Immune Medical In…Preclinical

Infusion of lentiviral TYF-CGD-modified autologous stem cells (Infusion of lentiviral TYF-CGD-modified autologous stem cells)

Chronic Granulomatous Disease · Chronic Granulomatous Disease

#ChronicGranulomatousDisease#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleMinicirclePhase 1

Injectable Plasmid Klotho Gene Therapy (Injectable Plasmid Klotho Gene Therapy)

Healthy Adults · Healthy Adults

#HealthyAdults#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Innovator infliximab (Innovator infliximab)

Rheumatoid Arthritis; Spondyloarthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystalePfizerPhase 3

Inotuzumab (Inotuzumab)

Acute Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
ADCBiologicstalePfizerPhase 3

INO (Inotuzumab ozogamicin, Inotuzumab ozogamicin (INO))

B-Cell Acute Lymphoblastic Leukaemia · B-Cell Acute Lymphoblastic Leukaemia

#B-CellAcuteLymphoblasticLeukaemi#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleNational University Hospital, S…Phase 1

Interleukin, NK cells (Interleukin, NK cells)

Metastatic Nasopharyngeal · Metastatic Nasopharyngeal

#MetastaticNasopharyngeal#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleWenbin QianPhase 2

Interleukin-7 and Chemokine (C-C Motif, Interleukin-7 and Chemokine, Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T cells)

B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleNorthwell HealthPhase 1

trastuzumab (Herceptin, Intra-arterial Cerebral Infusion of Trastuzumab)

Neoplasm Metastasis · Neoplasm Metastasis

#NeoplasmMetastasis#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Intra-arterial Cetuximab (Intra-arterial Cetuximab)

Glioblastoma; Anaplastic Astrocytoma · Glioblastoma

#Glioblastoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Intraarticular injection of infliximab (Intraarticular injection of infliximab)

Arthritis · Arthritis

#Arthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleT-MAXIMUM Pharmaceutical IncPhase 2

Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3 (Intracerebroventricular injection of MT027 UCAR-T Cell targeting B7H3)

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Glioblastoma IDH (Isocitrate Dehydrogena

#GlioblastomaIDHIsocitrateDehydro#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystaleKhon Kaen UniversityPhase 3

Intralesional injection of bevacizumab (Intralesional injection of bevacizumab)

Pterygium; Inflammation · Pterygium

#Pterygium#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleHospices Civils de LyonPhase 2

nivolumab (Opdivo, IP, Intraperitoneal, Intraperitoneal (IP) nivolumab infusion)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEastern Regional Medical CenterPhase 1

Intraperitoneal Bevacizumab (Intraperitoneal Bevacizumab)

Malignant Ascites · Malignant Ascites

#MalignantAscites#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleWeijia Fang, MDPhase 1

Intraperitoneal infusion of FAST CEA-targeted CAR-T (Intraperitoneal infusion of FAST CEA-targeted CAR-T)

Colorectal Cancer; Solid Cancers · CEA

#CEA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

Intrathecal Rituximab (Intrathecal Rituximab)

Leukemia; Lymphoid Malignancies · Leukemia

#Leukemia#Antibody#Phase2#항체#면역항체+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
AntibodystaleShanghai Cancer Hospital, ChinaPhase 2

nivolumab (Opdivo, Intraventricular Nivolumab)

Leptomeningeal Metastasis · Leptomeningeal Metastasis

#LeptomeningealMetastasis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING

124 / 177 페이지

← 이전다음 →